Koon Swee Lim

Koon Swee Lim is a consultant at Helix - Population Genomics, a position he has held since July 2021. He is based in Singapore and has a robust background in the healthcare and biotechnology sectors, with extensive experience in business operations and management across the Asia Pacific region.

Professional Experience

• Helix - Population Genomics: Consultant (July 2021 - Present)

• Medilot Technologies Pte Ltd: CEO (March 2019 - Present) - Focuses on health data analytics as a service.

• Vanguard Medical Pte Ltd: Consultant (April 2018 - February 2019).

• Egis Healthcare Technologies Pte Ltd: VP of Operations (January 2016 - March 2018).

• Vanguard Medical Pte Ltd: Managing Partner (March 2012 - December 2015).

• Exploit-Tech: VP (April 2009 - March 2012).

• German Based Company: Regional Managing Director, Asia Pacific (January 2006 - March 2009) - Responsible for establishing business operations in the region.

• Chiron/Novartis: Regional Chief Representative, Commercial Development, Asia Pacific (January 2001 - December 2004).

• Roche Diagnostics Asia Pacific: Corporate Vice President (June 1997 - December 2000).

• Abbott Laboratories: Regional Business Development Manager, South Asia (May 1996 - May 1997).

• Becton Dickinson Asia Pacific HQ: Regional Product Manager (January 1994 - April 1996).

• Beckman Instruments: Regional Market Executive (January 1990 - December 1994).

• Institute of Molecular and Cell Biology: Graduate Research Officer (May 1987 - December 1989).

Education

Koon Swee Lim holds a Bachelor of Science (Honors) degree in Microbiology/Molecular Biology from the National University of Singapore. He has also attended Hwa Chong and INSEAD, although specific details regarding degrees or programs at these institutions are not provided in the available information.

His extensive career in the healthcare and biotechnology sectors highlights his expertise in business development, operations management, and strategic consultancy within the Asia Pacific region.